vs

Side-by-side financial comparison of Evolus, Inc. (EOLS) and RE/MAX Holdings, Inc. (RMAX). Click either name above to swap in a different company.

Evolus, Inc. is the larger business by last-quarter revenue ($90.3M vs $71.1M, roughly 1.3× RE/MAX Holdings, Inc.). RE/MAX Holdings, Inc. runs the higher net margin — 2.0% vs 0.1%, a 1.9% gap on every dollar of revenue. On growth, Evolus, Inc. posted the faster year-over-year revenue change (14.4% vs -1.8%). RE/MAX Holdings, Inc. produced more free cash flow last quarter ($33.5M vs $11.3M). Over the past eight quarters, Evolus, Inc.'s revenue compounded faster (23.4% CAGR vs -4.7%).

Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.

RE/MAX is an international real estate franchise operating in over 100 countries and territories that, in 2015, had over 100,000 agents in 6,800 offices.

EOLS vs RMAX — Head-to-Head

Bigger by revenue
EOLS
EOLS
1.3× larger
EOLS
$90.3M
$71.1M
RMAX
Growing faster (revenue YoY)
EOLS
EOLS
+16.2% gap
EOLS
14.4%
-1.8%
RMAX
Higher net margin
RMAX
RMAX
1.9% more per $
RMAX
2.0%
0.1%
EOLS
More free cash flow
RMAX
RMAX
$22.2M more FCF
RMAX
$33.5M
$11.3M
EOLS
Faster 2-yr revenue CAGR
EOLS
EOLS
Annualised
EOLS
23.4%
-4.7%
RMAX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EOLS
EOLS
RMAX
RMAX
Revenue
$90.3M
$71.1M
Net Profit
$130.0K
$1.4M
Gross Margin
65.7%
Operating Margin
4.7%
13.1%
Net Margin
0.1%
2.0%
Revenue YoY
14.4%
-1.8%
Net Profit YoY
101.9%
-75.2%
EPS (diluted)
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EOLS
EOLS
RMAX
RMAX
Q4 25
$90.3M
$71.1M
Q3 25
$69.0M
$73.2M
Q2 25
$69.4M
$72.8M
Q1 25
$68.5M
$74.5M
Q4 24
$78.9M
$72.5M
Q3 24
$61.1M
$78.5M
Q2 24
$66.9M
$78.5M
Q1 24
$59.3M
$78.3M
Net Profit
EOLS
EOLS
RMAX
RMAX
Q4 25
$130.0K
$1.4M
Q3 25
$-15.7M
$4.0M
Q2 25
$-17.1M
$4.7M
Q1 25
$-18.9M
$-2.0M
Q4 24
$-6.8M
$5.8M
Q3 24
$-19.2M
$966.0K
Q2 24
$-11.3M
$3.7M
Q1 24
$-13.1M
$-3.4M
Gross Margin
EOLS
EOLS
RMAX
RMAX
Q4 25
65.7%
Q3 25
66.5%
Q2 25
65.3%
Q1 25
68.1%
Q4 24
66.7%
Q3 24
68.9%
Q2 24
70.3%
Q1 24
68.3%
Operating Margin
EOLS
EOLS
RMAX
RMAX
Q4 25
4.7%
13.1%
Q3 25
-16.7%
25.0%
Q2 25
-14.7%
19.3%
Q1 25
-22.1%
7.2%
Q4 24
-2.9%
5.9%
Q3 24
-25.3%
19.4%
Q2 24
-11.5%
20.6%
Q1 24
-15.0%
5.8%
Net Margin
EOLS
EOLS
RMAX
RMAX
Q4 25
0.1%
2.0%
Q3 25
-22.8%
5.4%
Q2 25
-24.7%
6.4%
Q1 25
-27.6%
-2.6%
Q4 24
-8.6%
8.0%
Q3 24
-31.4%
1.2%
Q2 24
-17.0%
4.7%
Q1 24
-22.1%
-4.3%
EPS (diluted)
EOLS
EOLS
RMAX
RMAX
Q4 25
$0.01
Q3 25
$-0.24
Q2 25
$-0.27
Q1 25
$-0.30
Q4 24
$-0.11
Q3 24
$-0.30
Q2 24
$-0.18
Q1 24
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EOLS
EOLS
RMAX
RMAX
Cash + ST InvestmentsLiquidity on hand
$53.8M
$118.7M
Total DebtLower is stronger
$146.1M
$432.2M
Stockholders' EquityBook value
$-23.1M
$452.4M
Total Assets
$225.9M
$582.5M
Debt / EquityLower = less leverage
0.96×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EOLS
EOLS
RMAX
RMAX
Q4 25
$53.8M
$118.7M
Q3 25
$43.5M
$107.5M
Q2 25
$61.7M
$94.3M
Q1 25
$67.9M
$89.1M
Q4 24
$87.0M
$96.6M
Q3 24
$85.0M
$83.8M
Q2 24
$93.7M
$66.1M
Q1 24
$97.0M
$82.1M
Total Debt
EOLS
EOLS
RMAX
RMAX
Q4 25
$146.1M
$432.2M
Q3 25
$433.3M
Q2 25
$434.4M
Q1 25
$121.8M
$435.3M
Q4 24
$121.5M
$436.2M
Q3 24
$121.2M
$437.2M
Q2 24
$120.9M
$438.1M
Q1 24
$120.6M
$439.0M
Stockholders' Equity
EOLS
EOLS
RMAX
RMAX
Q4 25
$-23.1M
$452.4M
Q3 25
$-28.8M
$448.1M
Q2 25
$-18.7M
$442.4M
Q1 25
$-6.6M
$433.5M
Q4 24
$5.5M
$429.5M
Q3 24
$5.9M
$423.1M
Q2 24
$19.3M
$418.4M
Q1 24
$18.4M
$412.0M
Total Assets
EOLS
EOLS
RMAX
RMAX
Q4 25
$225.9M
$582.5M
Q3 25
$219.0M
$582.2M
Q2 25
$228.8M
$574.8M
Q1 25
$213.4M
$571.4M
Q4 24
$232.6M
$581.6M
Q3 24
$229.6M
$578.6M
Q2 24
$233.8M
$571.4M
Q1 24
$226.2M
$566.7M
Debt / Equity
EOLS
EOLS
RMAX
RMAX
Q4 25
0.96×
Q3 25
0.97×
Q2 25
0.98×
Q1 25
1.00×
Q4 24
22.00×
1.02×
Q3 24
20.58×
1.03×
Q2 24
6.26×
1.05×
Q1 24
6.54×
1.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EOLS
EOLS
RMAX
RMAX
Operating Cash FlowLast quarter
$12.8M
$40.9M
Free Cash FlowOCF − Capex
$11.3M
$33.5M
FCF MarginFCF / Revenue
12.6%
47.1%
Capex IntensityCapex / Revenue
1.6%
10.4%
Cash ConversionOCF / Net Profit
98.67×
28.39×
TTM Free Cash FlowTrailing 4 quarters
$-45.7M
$56.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EOLS
EOLS
RMAX
RMAX
Q4 25
$12.8M
$40.9M
Q3 25
$-14.7M
$17.7M
Q2 25
$-24.8M
$4.6M
Q1 25
$-15.6M
$5.7M
Q4 24
$4.8M
$59.7M
Q3 24
$-5.7M
$17.6M
Q2 24
$-6.5M
$15.9M
Q1 24
$-10.6M
$9.4M
Free Cash Flow
EOLS
EOLS
RMAX
RMAX
Q4 25
$11.3M
$33.5M
Q3 25
$-15.6M
$16.4M
Q2 25
$-25.5M
$2.9M
Q1 25
$-16.0M
$4.0M
Q4 24
$4.4M
$53.0M
Q3 24
$-6.0M
$16.3M
Q2 24
$-6.9M
$14.0M
Q1 24
$-10.9M
$6.8M
FCF Margin
EOLS
EOLS
RMAX
RMAX
Q4 25
12.6%
47.1%
Q3 25
-22.7%
22.4%
Q2 25
-36.7%
4.0%
Q1 25
-23.3%
5.3%
Q4 24
5.5%
73.2%
Q3 24
-9.9%
20.8%
Q2 24
-10.4%
17.8%
Q1 24
-18.3%
8.6%
Capex Intensity
EOLS
EOLS
RMAX
RMAX
Q4 25
1.6%
10.4%
Q3 25
1.4%
1.8%
Q2 25
1.0%
2.2%
Q1 25
0.5%
2.3%
Q4 24
0.6%
9.1%
Q3 24
0.5%
1.7%
Q2 24
0.7%
2.4%
Q1 24
0.4%
3.3%
Cash Conversion
EOLS
EOLS
RMAX
RMAX
Q4 25
98.67×
28.39×
Q3 25
4.45×
Q2 25
0.97×
Q1 25
Q4 24
10.28×
Q3 24
18.22×
Q2 24
4.29×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EOLS
EOLS

Segment breakdown not available.

RMAX
RMAX

Franchising Segment$50.1M70%
Broker Fees$13.9M20%
Annual Dues$7.4M10%

Related Comparisons